ARCHIVES

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

This article is from The Cancer Letter archive.

Vol. 25 No. 6 | June 28, 2002

Download PDF Visit The Full Archive

Related Articles

Half of New NCI Funds in FY02 Spent on Grants

November 22, 2002

Okunieff To Lead SWOG Radiation Committee

July 19, 2002

Decision Delayed On Breast Cancer Study Until After Consensus Meeting

July 5, 1985

First Panel Meeting On Centers Generates Possible Recommendations For Core Grant Guideline Changes

April 6, 1984

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

July 25, 2014

New Mexico, Missouri, Columbia Next for Review As comprehensive Centers; UCLA Decision In October

September 17, 1976